Form 8.3 - Aon plc

Form 8.3 - Aon plc

BARCLAYS PLC

 

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1) Barclays PLC.
Company dealt in AON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 14 May 2020

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security: ORD

Long

Short

Number

(%)

Number

(%)

(1)

Relevant securities

 

 

 

 

251,606

0.11%

859,488

0.37%

 

 

 

 

(2)

Derivatives (other than options):

 

 

 

 

429,369

0.19%

29,700

0.01%

 

 

 

 

(3)

Options and agreements to

 

 

 

 

purchase/sell:

2,600

0.00%

4,500

0.00%

 

 

 

 

TOTAL:

 

 

 

 

683,575

0.30%

893,688

0.39%

 

 

 

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale

Number of relevant securities

Price per unit

Purchase

69

191.1317 USD

Purchase

100

193.8000 USD

Purchase

100

190.9900 USD

Purchase

157

188.1661 USD

Purchase

200

191.8550 USD

Purchase

295

191.3540 USD

Purchase

300

191.7133 USD

Purchase

341

188.0372 USD

Purchase

347

193.5980 USD

Purchase

400

187.4150 USD

Purchase

436

189.5639 USD

Purchase

452

188.8217 USD

Purchase

500

191.7610 USD

Purchase

650

188.9332 USD

Purchase

680

190.1270 USD

Purchase

801

189.7032 USD

Purchase

804

190.4043 USD

Purchase

900

191.5344 USD

Purchase

1,060

190.0920 USD

Purchase

1,088

192.3948 USD

Purchase

1,216

191.2511 USD

Purchase

1,266

187.5300 USD

Purchase

1,289

193.7994 USD

Purchase

1,372

191.3194 USD

Purchase

1,747

187.2938 USD

Purchase

1,799

193.1956 USD

Purchase

1,875

192.1298 USD

Purchase

3,896

190.0136 USD

Purchase

6,167

193.9300 USD

Purchase

6,400

189.5483 USD

Purchase

12,000

188.9703 USD

Purchase

14,500

189.5492 USD

Purchase

17,823

191.2124 USD

Sale

3

188.3100 USD

Sale

7

193.9800 USD

Sale

8

191.5450 USD

Sale

8

188.6000 USD

Sale

19

187.4000 USD

Sale

29

188.7700 USD

Sale

50

191.8600 USD

Sale

59

187.5300 USD

Sale

62

188.2241 USD

Sale

66

191.2600 USD

Sale

100

193.6300 USD

Sale

100

187.8000 USD

Sale

100

193.8700 USD

Sale

100

191.2100 USD

Sale

100

191.3200 USD

Sale

100

188.7900 USD

Sale

100

191.5700 USD

Sale

100

186.7500 USD

Sale

129

191.8958 USD

Sale

167

193.7523 USD

Sale

186

187.0788 USD

Sale

188

187.0478 USD

Sale

200

191.0270 USD

Sale

200

190.9500 USD

Sale

245

193.4597 USD

Sale

300

193.8500 USD

Sale

300

191.9500 USD

Sale

548

190.8830 USD

Sale

600

191.7683 USD

Sale

1,281

188.0924 USD

Sale

1,386

191.5171 USD

Sale

1,573

188.6488 USD

Sale

4,202

190.1861 USD

Sale

5,300

191.3646 USD

Sale

7,000

190.2761 USD

Sale

7,300

188.8139 USD

Sale

7,708

190.6429 USD

Sale

7,711

193.9300 USD

Sale

9,100

188.4737 USD

Sale

10,837

191.5759 USD

Sale

13,604

189.8060 USD

(b) Derivatives transactions (other than options transactions)

Product Name

Nature of transaction

Number of relevant securities

Price per

 

 

unit

SWAP

Long

508

190.6121 USD

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

(ii) Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure:

15 May 2020

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection

Ap23

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

Product name

Written or 

Number of

Exercise

Type

Expiry

 

purchased

relevant securities 

price

 

date

 

 

to which the option 

 

 

 

 

 

or derivative 

 

 

 

 

 

relates

 

 

 

Call Options

  Purchased

1,100

260.0000 

American

Jul 17, 2020

Call Options

  Purchased

1,500

240.0000 

American

Jul 17, 2020

Call Options

  Written

-4,500

220.0000 

American

Jul 17, 2020

Notes

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

2. For all prices and other monetary amounts, the currency must be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

UK 100

Latest directors dealings